TickerFacts.

Bioventus Inc. (BVS): Operating Cash Flow

Annual figures by period end, from SEC filings.

$74.67M
Year ended 2025-12-31
$96.87M
Trailing 12 months to 2026-06-27
+0.8%
5-year compound annual growth
2019-12-31: $40.71M2020-12-31: $71.80M2021-12-31: $22.99M2022-12-31: -$13.54M2023-12-31: $15.34M2024-12-31: $38.80M2025-12-31: $74.67M$74.67M
2019-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$74.67M+92.5%2026-03-05, From 2025-01-01
2024-12-31$38.80M+152.8%2026-03-05, From 2024-01-01
2023-12-31$15.34Mn/m2026-03-05, From 2023-01-01
2022-12-31-$13.54Mn/m2025-03-11, From 2022-01-01
2021-12-31$22.99M-68.0%2024-03-12, From 2021-01-01
2020-12-31$71.80M+76.4%2023-03-31, From 2020-01-01
2019-12-31$40.71Mn/a2022-03-11, From 2019-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Bioventus Inc. (BVS)2025-12-31$74.67M+92.5%
UFP Technologies Inc (UFPT)2025-12-31$91.91M+38.0%
AtriCure, Inc. (ATRC)2025-12-31$57.33M+369.8%
Glaukos Corp (GKOS)2025-12-31-$14.79Mn/m
NovoCure Ltd (NVCR)2025-12-31-$49.03Mn/m
Artivion, Inc. (AORT)2025-12-31$39.88M+79.3%
iRhythm Holdings, Inc. (IRTC)2025-12-31$80.86Mn/m
Alphatec Holdings, Inc. (ATEC)2025-12-31$45.23Mn/m
Mimedx Group, Inc. (MDXG)2025-12-31$74.00M+11.8%

Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗